Behavioral Telehealth Loses Momentum Without a Regulatory Boost

As flexible treatment options spurred by the covid pandemic wane, patients relying on medications classified as controlled substances worry that without action to extend the loosened rules, it’ll be harder to get their meds.
http://dlvr.it/SgfJFg

Comments

Popular posts from this blog

Bustos on Bloomberg TV: In Last Two Weeks, “Price of Gas Has Gone Down Forty Cents”